ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year. Incremental Payments Received based on Executed Global Licensing Agreements that could provide up to $292 million in income Received Cash …